MyOme
Provides clinical whole genome analysis for personalized health insights.
Sequoia — Backed by Sequoia H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.Company facts
- Founded
- 2017
- Employees
- 89
- Headquarters
- United States
- CEO
- Premal Shah, PhD
- Type
- Private
- Funding
- Series B · $23M · 2022
About
At MyOme, we’re pioneering the future of genomic medicine, empowering individuals and healthcare providers with advanced insights to guide health decisions. Built by leading scientists, engineers, and clinicians, MyOme is dedicated to unlocking the full potential of the genome to improve health outcomes. Founded in 2017 by a diverse group of experts, MyOme aims to provide genomic insights for everyone. We help assess risks for rare and common hereditary conditions, equipping individuals and healthcare providers with the necessary tools to make informed decisions. From the start, we’ve prioritized secure, portable genomic data that is always owned by the individual. Our mission is to combine whole genome sequencing with cutting-edge bioinformatics, making meaningful genetics-driven insights the standard of care.